Identification of artifacts, normal structures that resemble lesions, lesions that are not associated with clinical signs, and postmortem changes, are an important aspect of diagnosing central nervous ...

MAIDENHEAD, England--(BUSINESS WIRE)--RWS (RWS.L), a global AI solutions company, announces the launch of a new rater training, certification and retraining service designed specifically to improve ...

Despite years of guidelines cautioning against their use, potentially inappropriate central nervous system (CNS)-active medications are commonly prescribed to older adults —particularly those with ...

China’s newest aircraft carrier CNS Fujian (18) sailed through the Taiwan Strait on Dec. 16, 2025. Taiwan Ministry of National Defense photo The People’s Liberation Army Navy newest aircraft carrier ...

This includes diagnosis and treatment of common acute and chronic disease that affect the general health of the client. Services include first contact with a client for an undiagnosed health concern, ...

China officially put its most-advanced aircraft carrier, CNS Fujian, into service at a ceremony attended by President Xi Jinping on Wednesday, marking a major milestone for the East Asian power in ...

China has commissioned the CNS Fujian, making it the third nation with an in-service CATOBAR (catapult-assisted take-off but arrested recovery) aircraft carrier. Video posted on Chinese social media ...

Panelists discuss how CNS-active EGFR TKIs are improving intracranial outcomes and influencing treatment selection in NSCLC. Panelists discuss how central nervous system (CNS) involvement in non–small ...

WASHINGTON — President Donald Trump will undergo a physical exam on Friday following mounting questions about his health prompted by noticeable bruising and swelling in recent months. “On Friday ...

WASHINGTON, Oct 8 (Reuters) - U.S. President Donald Trump will undergo what the White House described as his "routine yearly checkup" on Friday at Walter Reed medical center, six months after he had ...

CNS metastases in EGFR-mutant NSCLC are prevalent and worsen prognosis, especially with acquired progression during treatment. Amivantamab plus lazertinib shows promising CNS activity, but current ...

The risk for central nervous system (CNS) involvement is small in cases of diffuse large B-cell lymphoma (DLBCL) because only about 5% of patients develop it. But certain high-risk patients are even ...